九强生物收盘上涨2.28%，滚动市盈率16.49倍，总市值81.66亿元

Core Viewpoint - The company Jiukang Bio has a current stock price of 13.88 yuan, with a rolling PE ratio of 16.49, which is the lowest in the past 15 days, and a total market capitalization of 8.166 billion yuan [1]. Company Summary - Jiukang Bio specializes in the research, production, and sales of biochemical diagnostics, blood coagulation testing, blood type testing, and tumor pathology diagnostics [1]. - The main products include in vitro diagnostic reagents, in vitro testing instruments, instrument leasing, inspection services, laboratory assistance, and other businesses [1]. - The company was recognized as a "National Enterprise Technology Center" on February 22, 2023, as part of the 29th batch of newly recognized national enterprise technology centers [1]. Financial Performance - For the first quarter of 2025, Jiukang Bio reported an operating income of 320 million yuan, a year-on-year decrease of 18.81%, and a net profit of 83.2575 million yuan, down 30.99% year-on-year, with a gross profit margin of 80.84% [1]. Industry Comparison - The average PE ratio for the medical device industry is 50.80, with a median of 36.71, placing Jiukang Bio at the 39th position within the industry [1][2]. - The company has a total of 8 institutional holders, including 7 funds, with a total holding of 131.7025 million shares valued at 2.06 billion yuan [1].